comparemela.com
Home
Live Updates
UCB Reinforces Commitment to Rheumatology With 15 Abstracts Including New Late-Breaking Data at ACR Convergence 2022 : comparemela.com
UCB Reinforces Commitment to Rheumatology With 15 Abstracts Including New Late-Breaking Data at ACR Convergence 2022
/PRNewswire/ -- UCB, a global biopharmaceutical company, today announced that it will present 15 abstracts across its rheumatology portfolio at ACR Convergence...
Related Keywords
United Kingdom
,
Brussels
,
Bruxelles Capitale
,
Belgium
,
Philadelphia
,
Pennsylvania
,
United States
,
Smyrna
,
Izmir
,
Turkey
,
Great Britain
,
Nicole Herga
,
Emmanuel Caeymaex
,
J Clin Pharmacol
,
Antje Witte
,
Immunology Solutions
,
Twitter
,
Bimekizumab Treatment Improves Health
,
Ucb Inc
,
Drug Administration
,
Group Of Companies
,
European Union Eu Economic Area
,
Us Immunology Communications
,
Source Ucb Inc
,
Executive Vice President
,
Psoriatic Arthritis
,
Active Psoriatic Arthritis
,
Week Efficacy
,
Safety Results
,
Active Reference
,
Inadequate Response
,
Tumor Necrosis Factor Inhibitors
,
Treatment Improves Health Related Quality
,
Active Psa
,
Week Results From Two Phase
,
Disease Activity Assessed
,
Composite Endpoints
,
Week Results
,
Treatment Results
,
Two Phase
,
Greater Improvements
,
Patient Centric Measures
,
Physical Function
,
Maintains Improvements
,
Efficacy Endpoints
,
Consistent Safety Profile Through
,
Non Radiographic Axial Spondyloarthritis
,
Ankylosing Spondylitis
,
Two Parallel Phase
,
Improves Signs
,
Including Inflammation
,
Active Non Radiographic Axial Spondyloarthritis
,
Active Ankylosing Spondylitis
,
Safety From
,
Placebo Controlled
,
Improves Key Patient Reported Symptoms
,
Axial Spondyloarthritis Including Spinal Pain
,
Improves Physical Function
,
Health Related Quality
,
Axial Spondyloarthritis
,
Results From Two Phase
,
Increasingly Stringent Clinical Response Criteria
,
Lower Levels
,
Patients With Active Axial Spondyloarthritis
,
Exploratory Analysis
,
Clinical Response
,
Certolizumab Pegol Treatment
,
Active Axial
,
Term Clinical Outcomes
,
Active Non
,
Radiographic Axial Spondyloarthritis Stratified
,
C Reactive Protein
,
Preliminarily Proposed
,
Sacroiliac Joints
,
Axial Spondyloarthritis Patients
,
European Union
,
European Economic Area
,
Euronext Brussels
,
Product Characteristics
,
comparemela.com © 2020. All Rights Reserved.